|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Carnitine, Free & Total
Test CodeCARN
Alias/See Also
Carnitine
Preferred Specimen
1 mL serum
Minimum Volume
0.2 mL
Transport Container
Plastic vial
Transport Temperature
Frozen
Specimen Stability
7 days ambient, freezing of specimen is preferred
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis, gross lipemia, gross icterus
Report Available
3-6 days
Reference Range
See report for normal ranges.
Clinical Significance
Evaluation of carnitine in serum, plasma, tissue, and urine screens patients for suspected primary disorders of the carnitine cycle, or secondary disturbances in carnitine levels as a result of organic acidemias and fatty acid oxidation disorders. In the latter disorders, acyl-CoA groups accumulate and are excreted into the urine and bile as carnitine derivatives, resulting in a secondary carnitine deficiency. More than 100 such primary and secondary disorders have been described. Individually, the incidence of these disorders varies from <1 in 10,000 to >1 in 1,000,000 live births. Collectively, their incidence is approximately 1 in 1,000 live births. Other conditions which could cause an abnormal carnitine level are neuromuscular diseases, gastrointestinal disorders, familial cardiomyopathy, renal tubulopathies and chronic renal failure (dialysis), and prolonged treatment with steroids, antibiotics (pivalic acid), anticonvulsants (valproic acid), and total parenteral nutrition